Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Vanguard Short-Term Bond ETF
BSV
$45.7B
| $14.3M | 0.02% |
182,446
+3,023
| +2% | +$236K |
|
902
Seacoast Banking Corp of Florida
SBCF
$3.29B
| $14.3M | 0.02% |
550,543
+272,351
| +98% | +$7.3M |
|
903
Medpace
MEDP
$17.1B
| $14.3M | 0.02% |
269,626
-109,063
| -29% | -$5.99M |
|
|
TELL
904
DELISTED
Tellurian Inc.
TELL
| $14.2M | 0.02% |
2,048,386
+1,341,390
| +190% | +$10.4M |
|
905
Essential Properties Realty Trust
EPRT
$6.66B
| $14.2M | 0.02% |
1,027,799
-704,282
| -41% | -$9.79M |
|
906
Ironwood Pharmaceuticals
IRWD
$725M
| $14.2M | 0.02% |
1,639,458
+1,327,506
| +426% | +$15.2M |
|
907
W.R. Berkley
WRB
$25.4B
| $14.2M | 0.02% |
648,395
+491,130
| +312% | +$11M |
|
908
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $14.2M | 0.02% |
+536,200
| New | +$14.6M |
|
|
ORBK
909
DELISTED
Orbotech Ltd
ORBK
| $14.1M | 0.02% |
250,256
-292,699
| -54% | -$16.4M |
|
910
nVent Electric
NVT
$24.5B
| $14.1M | 0.02% |
629,272
-316,927
| -33% | -$7.67M |
|
911
Alaska Air
ALK
$4.84B
| $14.1M | 0.02% |
+232,192
| New | +$15M |
|
912
Cabot Corp
CBT
$4.32B
| $14.1M | 0.02% |
328,951
-57,280
| -15% | -$2.85M |
|
913
PUT
Mondelez International
MDLZ
$80.4B
| $14.1M | 0.02% |
352,800
+60,000
| +20% | +$2.56M |
|
|
WWE
914
DELISTED
World Wrestling Entertainment
WWE
| $14.1M | 0.02% |
188,919
-338,257
| -64% | -$25.4M |
|
|
RSX
915
PUT
DELISTED
VanEck Russia ETF
RSX
| $14.1M | 0.02% |
752,500
+412,000
| +121% | +$8.46M |
|
916
Sibanye-Stillwater
SBSW
$8.87B
| $14.1M | 0.02% |
4,982,009
+2,629,855
| +112% | +$7.12M |
|
|
CCH.U
917
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
| $14.1M | 0.02% |
+1,400,000
| New | +$14.2M |
|
918
Booz Allen Hamilton
BAH
$8.88B
| $14.1M | 0.02% |
312,126
-432,119
| -58% | -$21.2M |
|
919
Copart
CPRT
$30.9B
| $14.1M | 0.02% |
1,176,296
+849,540
| +260% | +$10.5M |
|
920
Kraft Heinz
KHC
$30B
| $14M | 0.02% |
326,057
-2,006,784
| -86% | -$104M |
|
921
Banner Corp
BANR
$2.39B
| $14M | 0.02% |
262,112
-26,377
| -9% | -$1.53M |
|
922
CALL
Halliburton
HAL
$28.2B
| $14M | 0.02% |
526,400
+456,000
| +648% | +$15.4M |
|
|
VG
923
DELISTED
Vonage Holdings Corporation
VG
| $14M | 0.02% |
1,600,691
+727,349
| +83% | +$8.33M |
|
924
GSK
GSK
$104B
| $14M | 0.02% |
292,260
+251,213
| +612% | +$12.4M |
|
925
Acuity Brands
AYI
$10.2B
| $13.9M | 0.02% |
121,345
-192,408
| -61% | -$23.8M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.